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Abstract
Background: Glycosylated hemoglobin, HbA1c is the most acceptable measure of chronic glycemia. It is not widely 
available and/or affordable in Nigeria. The mean of the monthly fasting plasma glucose (MFPG) of the preceding 
3 months is often used as surrogate for assessing chronic glycemia.
Objective: To determine the relationships among fasting plasma glucose (FPG), 2-hour post-prandial glucose (2-hPG), 
HbA1c, and MFPG.
Materials and Methods: Hospital records were used to derive the MFPGs of diabetic subjects from the mean of their 
monthly FPGs of the preceding three months. Other data extracted included the patient’s age, sex, body mass index 
(BMI), waist circumference (WC), and duration of diabetes mellitus (DMDU). FPG, 2- hPG and HbA1c were determined 
during this index consultation.
Results: Ninety five persons (65 males, 30 females) with type 2 were included in the study. Their mean age and DMDU 
were 54.7 ± 8.9 years and 8.1 ± 6.1 years, respectively. Their mean WC, BMI, FPG, 2-hPG, HbA1c, and MFPG were 
100.2 ± 11.0 cm, 24.2 ± 4.3 kgm/2, 7.5 ± 2.4 mmol/l, 10.4 ± 4.1 mmol/l, 8.2 ± 2.2%, and 5.9 ± 2.2 mmol/l, respectively. The 
males were significantly older (57.5 ± 8.4 vs 49.3 ± 7.6, P<0.001) while the females had higher waist circumference and 
BMI than their male counterparts: 104.8 ± 11.6 cm vs 92.8 ± 10.1 cm, P<0.004; and 25.8 ± 4.9 kg/m2 vs 23.3 ± 3.7 kg/m2, 
P<0.005, respectively. There were no significant differences in FPG, 2-hPG, MFPG and HbA1c levels between male and 
female subjects. There were significant positive correlations between FPG and HbA1c (r=0.45, P=0.05) and between 
2-hPG and HbA1c (r=0.52, P=0.01), but there was no positive correlation between MFPG and HbA1c (r=−0.20, P=0.18).
Conclusion: There is no positive correlation between MFPG and HbA1c and thus MFPG may not be a good surrogate 
for HbA1c in assessment of chronic glycemia in our patients.
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Introduction
Hemoglobin A1c is formed from irreversible glycosylation of 
erythrocyte hemoglobin in proportion to circulating plasma 
levels of glucose.[1,2] HbA1c level provides an index of the 
average blood glucose concentration over the previous 
2‑3 months.[3‑5] Presently, HbA1c is the most acceptable and 
widely used measure of chronic glycemia.[2] Elevated HbA1c 
levels have been associated with long‑term complications of 
diabetes mellitus.[6,7] Its level is therefore used to determine 
whether treatment is adequate. Many Nigerians with 
diabetes mellitus do not achieve good long term glycemic 
control when HbA1c is used as an index of chronic glycemia. 
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Idogun and Olumese[8] reported that only 53% of 64 type 2 
diabetic patients seen in a tertiary medical centre in Benin 
City had good glycemic control. Adebisi et al.,[9] found only 
36% of diabetic patients had HbA1c≤7.2% in Ilorin.
Unfortunately HbA1c is not widely available and/or affordable 
in most hospitals in Africa,[10] Nigeria inclusive. In Nigeria, 
the mean of the three most recent fasting plasma glucose 
(MFPG) results documented in the patient’s last three 
hospital consultations is often calculated and used as 
surrogate for long term glycemia in place of HbA1c. However, 
it is not known with certainty if there is a strong correlation 
between the calculated mean fasting plasma glucose (MFPG) 
and HbA1c in Nigerians with type 2 diabetes mellitus. This 
study is to determine the relationship among HbA1c, fasting 
plasma glucose, 2‑h post‑prandial plasma glucose and the 
mean of the last three FPG levels of Nigerians with type 2 
diabetes mellitus with a view to determining the suitability 
or otherwise of using MFPG as a surrogate for HbA1c.
Materials and Methods
Hospital records of all patients with type 2 DM seen at the 
diabetes clinic over a 3‑month period were retrieved for 
the study. Data documented included the patient’s age, 
sex, body mass index (BMI), waist circumference (WC), 
and duration of diabetes mellitus. All consenting patients 
with type 2 diabetes mellitus were educated about the aim 
of the study and were instructed to come to the Diabetes 
Clinic fasting on test days.
On arrival at the Diabetes Clinic in the morning, blood 
samples were drawn for determination of FPG (after 
8‑10 hour overnight fast) and HbA1c. After which subjects 
drank within 5 minutes a glucose solution prepared by 
dissolving 75 g anhydrous glucose in 250 ml of water. 
Two hours later, blood samples were drawn to determine 
the 2‑h postprandial plasma glucose (2‑hPG). The mean 
fasting plasma glucose (MFPG) values was derived from the 
mean of the monthly FPG of the preceding three months 
documented in the patient’s hospital record.
Plasma glucose was determined by the glucose oxidase 
method of Trinder.[11] HbA1c level was determined with 
an automated HbA1c point‑of‑care‑testing analyser, the 
Bio‑Rad in2it (Bio‑Rad Laboratories Deeside, CH5 2NU, 
UK) using a drop of blood obtained by finger prick.
All the study subjects voluntarily gave informed consent. 
The Hospital Ethics and Research Committee approved 
the study.
Exclusion criteria
All pregnant subjects with type 2 diabetes mellitus, all type 1 
DM patients, all type 2 DM subjects who were unwilling 
to give consent for the study, those who were ill, and any 
subject who could not complete every aspect of the study 
were excluded.
Definition of terms
Good long term glycaemic control was defined according to the 
American Diabetes Association criteria[12] as a HbA1c<7%.
Statistical analysis
Statistical analysis was carried out using the Statistical Package 
for Social Sciences (SPSS) version 16. Data are expressed as 
mean±SD. Significance of difference in mean values was 
determined using a two‑tailed unpaired t‑test. Correlations 
among FPG, 2‑hPG, MFPG, and HbA1c were estimated using 
Pearson or Spearman correlation coefficients as appropriate. 
Level of statistical significance was set at P<0.05.
Results
Ninety five persons (65 males, 30 females) with type 2 were 
included in the study. Their mean age was 54.7 ± 8.9 years. 
The mean duration of diabetes mellitus was 8.1 ± 6.1 years. 
The mean of their waist circumstance, BMI, FPG, 2‑hPG, 
HbA1c, and MFPG were 100.2 ± 11.0 cm, 24.2 ± 4.3 kgm
−2, 
7.45 ± 2.4 mmol/l, 10.4 ± 4.1 mmol/L, 8.2 ± 2.2%, and 
5.9 ± 2.2 mmol/l. The characteristics of the study subjects 
by gender are summarized in [Table 1]. The males were 
significantly older (57.5 ± 8.4 vs 49.3 ± 7.6, P<0.001) while 
the females had higher waist circumference and BMI than 
their male counterparts: 104.8 ± 11.6 cm vs 92.8 ± 10.1 cm, 
P<0.004; and 25.8 ± 4.9 kg/m2 vs 23.3 ± 3.7 kg/m2, 
P<0.005, respectively. There were no significant differences 
in FPG, 2‑hPG, MFPG, and HbA1c levels between male and 
female subjects. Thirty‑five (37%) of them had good long‑term 
glycaemic control of the diabetes mellitus (HbA1c<7%)
There were significant positive correlations between FPG 
and HbA1c (r=0.45, P=0.05) and between 2hPG and HbA1c 
(r=0.52, P=0.01). There was no positive correlation observed 
between MFPG and HbA1c; r=−0.20, P=0.18 [Table 2].
Table 1: Characteristics of the study subjects 
mean±SD
Parameter Male Females P value
Age (years) 57.5 ± 8.4 49.3 ± 7.6 <0.001
BMI (kgm/2) 23.3 ± 3.7 25.8 ± 4.9 0.005
WC (cm) 92.8 ± 10.1 104.8 ± 11.6 0.004
DMDU (years) 8.0 ± 6.0 8.2 ± 6.2 0.892
FPG (mmol/l) 7.3 ± 2.4 7.7 ± 2.6 0.462
2hPG (mmol/l) 10.59 ± 4.2 9.93 ± 4.0 0.487
MFPG (mmol/l) 5.8 ± 2.3 6.3 ± 1.6 0.359
HbA
1c
 (%) 8.2 ± 2.3 8.2 ± 2.0 0.994
BMI = Body mass index, WC = Waist circumference, DMDU = Duration 
of diabetes, FPG = Fasting plasma glucose, 2hPG = Two hour 
postprandial plasma glucose, MFPG = Mean fasting plasma glucose, 
HbA1c = Glycosylated haemoglobin A1c
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Discussion
Our study showed that in Nigerians with type 2 diabetes 
mellitus, there was a significant positive correlation between 
fasting plasma glucose and HbA1c and an even stronger 
correlation between 2‑h post‑prandial plasma glucose 
and HbA1c. There was no positive correlation between 
the MFPG and HbA1c. These findings have important 
implications for our diabetic patients. The fasting plasma 
glucose is commonly done few days before or on the day 
of outpatient consultations. There are no local studies 
to validate any relationship between FPG and HbA1c. 
Otieno et al.,[13] reported that the morning random blood 
glucose (RBS) level had a linear relationship with glycated 
hemoglobin taken simultaneously when the RBS is less than 
10 mmol/l. Gill et al.,[14] documented a positive correlation 
between RBS and HbA1c (r=0.54). Further study is desirable 
to validate this in our locale.
The mean of the monthly fasting plasma glucose (MFPG) 
of the last three months was within acceptable target 
glycemic levels in our study. This gives a false sense of 
a good long‑term glycemic control whereas the HbA1c 
clearly showed that a majority (63%) of our patients had 
poor long term glycemic control as evidenced by values of 
HbA1c>7.0%. Our patients are generally not adherent to 
diet and anti‑diabetic drugs. They tend to maintain better 
glycemia immediately before and after the consultation. This 
is, however, not substained on a long‑term basis.
The correlation between FPG and HbA1c (r=0.45) and 
between 2‑h postprandial glucose and HbA1c (r=0.52) 
found in this study were smaller than those of r=0.71 and 
r=0.79 for FPG vs HbA1c and 2hPG vs HbA1c, respectively, 
documented by Van‑‘t Riet et al.,[15] in patients with diabetes 
mellitus in a Dutch population. Nathan et al.,[4] also reported 
that HbA1c correlated closely with a complete measure of 
average glycemia over the preceding 8‑12 weeks. Nathan 
and colleagues measured mean glucose levels by continuous 
glucose monitoring, which measured interstitial glucose 
levels every 5 min, for 12 weeks. A strong correlation 
between mean blood glucose and HbA1c in type 2 diabetes 
mellitus was also documented by Makris et al.,[5] among 
Greek patients with type 2 diabetes (r=0.92). In the Greek 
study, mean blood glucose was calculated for each patient 
from self measurements of blood glucose using a portable 
glucometer, made six times a day (before eating and 2 h 
after a meal), three times a week for 1 month.
There was, however, no positive correlation between 
the MFPG and HbA1c in our patients compared to those 
documented in Caucasians. In the Caucasian studies, 
mean blood glucose were determined by continuous blood 
glucose monitoring every 5 min, for 12 weeks by Nathan 
et al.,[4] six times a day, three times a week in the Makris 
et al.,[5] compared to the once‑a‑month FPG in our study. 
The mean of the glucose level from the continuous glucose 
monitoring is expectedly more likely to correlate with HbA1c. 
This is due to less day‑to‑day variability of fasting plasma 
glucose in diabetic patients when plasma fasting glucose is 
done on a daily basis[16] rather than it being done once a 
month.
In our study, 2hPG had a stronger correlation with HbA1c 
than FPG as in previous studies.[17,18] In an analysis of 
glucose profiles and HbA1c in the Diabetes Control and 
Complication Trial, Rohlfing et al.,[17] found that among 
individual time points, afternoon and evening plasma 
glucose (post lunch, pre‑dinner, post‑dinner, and bedtime) 
showed higher correlations with HbA1c than the morning 
time points (pre‑breakfast, post‑breakfast, and pre‑lunch). 
This finding is similar to that of Woerle et al.,[18] who 
noted that both FPG and 2‑hPG levels increased as HbA1c 
increased but that 2‑hPG level increased at a rate 4 times 
greater than FPG and accounted for a greater proportion 
of HbA1c.
Our patient characteristics such as age, gender and BMI 
were not associated with adequate glycaemic control. This 
observation was previously reported by Goudswaard et al.,[19] 
and was recently reaffirmed by Rätsep et al.[20]
In conclusion, MFPG derived from the mean of the monthly 
FPG done over the preceding 3 months in our patients with 
type 2 diabetes mellitus did not correlate positively with 
HbA1c and thus may not be a good surrogate for HbA1c as 
a measure of long‑term glycemic control. FPG and 2‑hPG 
both showed linear relationship with HbA1c; however, a 
larger scale study is needed to determine their usefulness 
as possible predictors of long term glycemic control in 
resource‑constraint environment. It is thus recommended 
that further studies involving patients who do their FPG 
weekly at least for 12 weeks should be done to assess if that will 
give a better correlation with HbA1c as continuous glucose 
monitoring is not feasible in our environment.
Limitation of study
The sample size is rather small due to the high cost of HbA1c 
and the difficulty in getting subjects with diabetes mellitus 
to participate in research in our practice locale.
Table 2: Correlation coefficient (r) between plasma 
glucose values and glycosylated haemoglobin (HbA
1c
)
FPG 2hPG MFPG HbA
1c
FPG 1 0.66** −0.18 0.45*
2hPG 0.66** 1 −0.20 0.52**
MFPG −0.18 −0.20 1 −0.20
HbA
1c
0.45* 0.52** −0.20 1
 *Correlation is significant at the 0.05 level (2‑ tailed); **Correlation is 
significant at the 0.01 level (2‑ tailed); FPG = Fasting plasma glucose; 
2hPG = 2‑h postprandial plasma glucose; MFPG = Most recent fasting 
plasma glucose ; HBA1C = hemoglobinA1C 
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